Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor beta by the monoclonal antibody fresolimumab (GC1008)

导出原文传递

翻译打印收藏纠错

作者： Lacouture, Mario E. ^[1] ; Morris, John C. ^[2] ; Lawrence, Donald P. ^[3] ; Tan, Antoinette R. ^[4] ; Olencki, Thomas E. ^[5] ; Shapiro, Geoffrey I. ^[6] ; Dezube, Bruce J. ^[7] ; Berzofsky, Jay A. ^[8] ; Hsu, Frank J. ^[9] ; Guitart, Joan

作者单位： NCI, Metab Branch & Vaccine Branch, Ctr Canc Res, Bethesda, MD 20892 USA ^[1] Northwestern Univ, Dept Dermatol, Chicago, IL 60611 USA ^[2] Ohio State Univ, Dept Med, Columbus, OH 43210 USA ^[3] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA ^[4] Mem Sloan Kettering Canc Ctr, Dept Med, Dermatol Serv, Outpatient Ctr, New York, NY 10065 USA ^[5] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA ^[6] Canc Inst New Jersey, Dept Med, New Brunswick, NJ USA ^[7] Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA ^[8] Genzyme Corp, Cambridge, MA USA ^[9]

关键词 Transforming growth factor beta GC1008 Fresolimumab Keratoacanthoma Squamous cell cancer

发布时间 2015-07-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交